• 1. An apparatus for determining small amounts of alchohol in sour milk and urine
  Analyst, 1964,89, 272-275
• 2. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 3. An aptamer-based keypad lock system?
  Yaqing Liu,Jiangtao Ren,Jing Li,Jiyang Liu,Erkang Wang Chem. Commun., 2012,48, 802-804
• 4. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
• 5. An integrated microfluidic platform for sensitive and rapid detection of biological toxins?
  Robert J. Meagher,Anson V. Hatch,Ronald F. Renzi,Anup K. Singh Lab Chip, 2008,8, 2046-2053

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Methylpyridines

Comprehensive Overview of (5-Methylpyridin-3-yl)methanamine (CAS No. 771574-45-9): Properties, Applications, and Industry Insights

(5-Methylpyridin-3-yl)methanamine, identified by its CAS No. 771574-45-9, is a specialized organic compound gaining traction in pharmaceutical and agrochemical research. This amine derivative, featuring a 5-methylpyridin-3-yl backbone, is valued for its unique structural properties and versatility in synthetic chemistry. As the demand for heterocyclic building blocks surges, this compound has emerged as a key intermediate in drug discovery pipelines.

The molecular structure of 771574-45-9 combines a pyridine ring with a methyl group at the 5-position and an aminomethyl substituent at the 3-position. This configuration enables diverse reactivity patterns, making it valuable for cross-coupling reactions and catalyzed transformations. Researchers frequently explore its potential in developing kinase inhibitors and CNS-targeting therapeutics, aligning with current trends in precision medicine.

Recent studies highlight the compound's role in structure-activity relationship (SAR) optimization. Its balanced lipophilicity and hydrogen-bonding capacity contribute to improved bioavailability profiles in lead compounds. Pharmaceutical developers are particularly interested in its application for neurodegenerative disease research, a hot topic in 2024 due to aging populations globally.

From a synthetic chemistry perspective, (5-Methylpyridin-3-yl)methanamine serves as a crucial precursor for chiral auxiliaries and ligand design. Its stability under various pH conditions makes it suitable for flow chemistry applications – a growing area in green chemistry initiatives. The compound's metal-chelating properties are also being investigated for catalytic systems in sustainable manufacturing processes.

Analytical characterization of CAS 771574-45-9 typically involves advanced techniques like LC-MS and NMR spectroscopy. Purity standards exceeding 98% are commonly required for pharmaceutical applications, driving innovations in chromatographic purification methods. These quality control aspects are critical for researchers addressing questions about compound reproducibility – a frequent concern in published literature.

The agrochemical sector has shown increasing interest in derivatives of 5-methylpyridin-3-ylmethanamine for developing next-generation crop protection agents. Its structural motifs appear in several neonicotinoid alternatives currently under evaluation, responding to environmental regulations and the search for bee-friendly pesticides – a trending topic in sustainable agriculture discussions.

Supply chain dynamics for 771574-45-9 reflect broader trends in fine chemical distribution. With major production hubs in Europe and Asia, manufacturers are adopting blockchain tracking for batch-to-batch consistency – a solution frequently searched by quality assurance professionals. The compound's shelf life and storage conditions (typically 2-8°C under inert atmosphere) are also common queries in technical forums.

Future research directions for (5-Methylpyridin-3-yl)methanamine may explore its potential in proteolysis targeting chimera (PROTAC) development and bioconjugation techniques. These cutting-edge applications align with industry needs for targeted protein degradation therapies and antibody-drug conjugates, areas generating significant scientific and investment interest currently.

• 63361-56-8(1-phenyl-N-(pyridin-3-ylmethyl)methanamine)
• 58123-56-1(Isoquinolin-4-ylmethanamine)
• 103921-71-7((5-Phenylpyridin-3-yl)methanamine)
• 3731-52-0(3-Picolylamine)
• 1346686-55-2({[3,3'-bipyridine]-5-yl}methanamine)
• 94413-66-8(3,5-Bis(aminomethyl)pyridine)
• 1020719-00-9(3-(AMINOMETHYL)PYRIDINE-2,4,5,6-D4)
• 84359-15-9( )
• 1346691-49-3((5-(p-Tolyl)pyridin-3-yl)methanamine)
• 1346691-47-1((5-(m-Tolyl)pyridin-3-yl)methanamine)